Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Search for other papers by Else Marie Opsahl in
Google Scholar
PubMed
Department of Pathology, Haukeland University Hospital Bergen, Bergen, Norway
Search for other papers by Lars Andreas Akslen in
Google Scholar
PubMed
Search for other papers by Ellen Schlichting in
Google Scholar
PubMed
Search for other papers by Turid Aas in
Google Scholar
PubMed
Search for other papers by Katrin Brauckhoff in
Google Scholar
PubMed
Search for other papers by Anne Irene Hagen in
Google Scholar
PubMed
Search for other papers by Alf Frimann Rosenlund in
Google Scholar
PubMed
Search for other papers by Eva Sigstad in
Google Scholar
PubMed
Search for other papers by Krystyna K. Grøholt in
Google Scholar
PubMed
Search for other papers by Lars H. Jørgensen in
Google Scholar
PubMed
Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
Search for other papers by Trine Bjøro in
Google Scholar
PubMed
, Plukker JT , Wolffenbuttel BH , Wiggers T , Sluiter WJ , Links TP . Determinants of life expectancy in medullary thyroid cancer: age does not matter . Clin Endocrinol (Oxf) . 2006 Dec ; 65 ( 6 ): 729 – 36 . 10.1111/j.1365-2265.2006.02659.x 17121523
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Elisabetta Cavedon in
Google Scholar
PubMed
Search for other papers by Sara Watutantrige-Fernando in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Maurizio Iacobone in
Google Scholar
PubMed
Search for other papers by Davide Nacamulli in
Google Scholar
PubMed
Search for other papers by Francesca Galuppini in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
A , Dralle H . Biomarker-based risk stratification for previously untreated medullary thyroid cancer . J Clin Endocrinol Metab . 2010 Jun ; 95 ( 6 ): 2655 – 63 . 10.1210/jc.2009-2368 20339026 0021-972X 6 Gharib H , McConahey
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Laure Cazabat in
Google Scholar
PubMed
Search for other papers by Aglae Terray in
Google Scholar
PubMed
Search for other papers by Philippe de Mazancourt in
Google Scholar
PubMed
Search for other papers by Jacques Ropers in
Google Scholar
PubMed
UMR 8104, Institut Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Inserm U1173, Université Versailles-Saint-Quentin, Montigny-Le-Bretonneux, France
Search for other papers by Marie-Laure Raffin-Sanson in
Google Scholar
PubMed
Assistance Publique Hôpitaux de Paris funding and a grant from the Direction Générale de l’Offre de Soin: PHRC AOR01093. References 1 Ngeow J, Eng C: HABP2 in familial non-medullary thyroid cancer: will the real mutation please stand up? J Natl
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Renata Alencar in
Google Scholar
PubMed
Search for other papers by Daniel Barretto Kendler in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Carla Nava in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Cencita Cordeiro de Noronha Pessoa in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
Incl Mol Pathol . 1992 ; 62 ( 2 ): 79 – 88 . 10.1007/BF02899668 1355324 0340-6075 11 Elisei R , Lorusso L , Romei C , Bottici V , Mazzeo S , Giani C , et al. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19
Search for other papers by Abbas Al-Kurd in
Google Scholar
PubMed
Search for other papers by David J. Gross in
Google Scholar
PubMed
Search for other papers by David Zangen in
Google Scholar
PubMed
Search for other papers by Karine Atlan in
Google Scholar
PubMed
Search for other papers by Haggi Mazeh in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H; European Multiple Endocrine Neoplasia Study Group: Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003; 349: 1517–1525. 10
Search for other papers by Marco Capezzone in
Google Scholar
PubMed
Search for other papers by Noemi Fralassi in
Google Scholar
PubMed
Search for other papers by Chiara Secchi in
Google Scholar
PubMed
Search for other papers by Silvia Cantara in
Google Scholar
PubMed
Search for other papers by Lucia Brilli in
Google Scholar
PubMed
Search for other papers by Tania Pilli in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Raffaella Forleo in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Gabriele Cevenini in
Google Scholar
PubMed
Search for other papers by Alessandra Cartocci in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Introduction The incidence of non-medullary thyroid cancer, in particular papillary thyroid cancer (PTC), has increased in many countries over the past 20 years [ 1 - 3 ]. As a consequence, also the reported incidence of the familial form of
Search for other papers by Sravanthi Nagavalli in
Google Scholar
PubMed
Search for other papers by Marelle Yehuda in
Google Scholar
PubMed
Search for other papers by Laron W. McPhaul in
Google Scholar
PubMed
Search for other papers by Andrew G. Gianoukakis in
Google Scholar
PubMed
. Negative staining for calcitonin, CEA, thyroglobulin, TTF1, melan-A, and HMB45 excluded melanoma, medullary thyroid cancer, and well-differentiated thyroid cancer. While on contrast-enhanced computed tomography the lesion had appeared intrinsic to the
Search for other papers by Furio Pacini in
Google Scholar
PubMed
the case of medullary thyroid cancer). Other recommendations are devoted to provide indications and timing for neck US and US-FNA. In the past literature, it was advocated that follow-up of thyroid cancer patients should go on for their entire lives
Search for other papers by Carles Zafon in
Google Scholar
PubMed
Department of Medicine, University of Alcalá de Henares, Madrid
Search for other papers by Juan J. Díez in
Google Scholar
PubMed
IdiSNA (Instituto de investigación en la salud de Navarra), Pamplona, Spain
Search for other papers by Juan C. Galofré in
Google Scholar
PubMed
Search for other papers by David S. Cooper in
Google Scholar
PubMed
>TGG) mutation. Endocr Relat Cancer 2008;15:1035-1041. 75 Hu MI, Ying AK, Jimenez C: Update on medullary thyroid cancer. Endocrinol Metab Clin North Am 2014;43:423-442. 76 Verbeek HH, Plukker JT, Koopmans KP, de Groot JW, Hofstra RM, Muller Kobold
Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy
Search for other papers by Giovanni Mauri in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Steven Bandula in
Google Scholar
PubMed
Search for other papers by Roberto Luigi Cazzato in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Oliver Dudeck in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Göran Wallin in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
). The efficacy decreased significantly according to the degree of tracheal abutment of the tumors [ 35 ]. Both LA and RFA may be used for the management of medullary thyroid cancer in patients not amenable to surgery [ 67 , 68 ]. A few case reports